The Petri Dish: Roche, Blueprint end lung cancer collab; Atea scraps dengue drug

Atea Pharmaceuticals is no longer working on a drug for dengue fever, citing a variety of challenges to running clinical studies.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news